Upadacitinib (Jak) monotherapy in rheumatoid arthritis

Double-blind, placebo-controlled trial of upadacitinib, a new oral Janus kinase (JAK) inhibitor, in patients with active rheumatoid arthritis (RA)

Lancet
Clinical Trial (NCT03086343)

Publicerat av

Liz

Until those day, was my kiss of death been stronger than those of the devil. I like to ride through hellfire with him ,when I come out victorious afterwards. I'm strong and proud rheumatoid arthritis warrior Följ mig, tack! Liz - Fotoblogg Spelblogg

En kommentar till “Upadacitinib (Jak) monotherapy in rheumatoid arthritis”

Kommentarer inaktiverade.